Prøve GULL - Gratis
“The concept of anti-ageing should, therefore, include youth preservation as part of its objective”
BioSpectrum Asia
|BioSpectrum Asia August 2022
Operating in approximately 50 markets worldwide in the Americas, Asia, Europe, Africa and the Pacific, Nu Skin is revolutionising the industry with products that offer comprehensive anti-ageing concerns. By targeting the ultimate sources of ageing, Nu Skin’s ageLOC products dramatically diminish the appearance of ageing. Backed by more than 35 years of scientific research, Nu Skin develops innovative products including Nu Skin personal care, Pharmanex nutrition and the ageLOC anti-ageing brand, which includes an award-winning line of beauty device systems. To find out more about the company’s expertise in the area of anti-ageing, BioSpectrum Asia spoke to Joseph Y. Chang, PhD, Chief Scientific Officer and Executive Vice President- Product Development, Nu Skin Enterprises. With over 35 years of experience in the pharmaceutical and dietary supplement industries, Dr Chang enjoys a comprehensive knowledge of both of these industries and serves as a member of the Executive Committee for Nu Skin Enterprises.
-
Edited excerpts;
What are your views on the growth and challenges of the antiageing market in Asian countries?
With the success of medicine and new technologies, people are living longer. With the rate of ageing in Asian countries accelerating and exceeding the rate of ageing in the western world, the anti-ageing market in Asia will grow to around $120 billion by 2030. And skin care products that address skin ageing form a significant percentage of this market.
An integrated approach of modern and ancient medicine to beauty and wellness is attractive to consumers. But the holistic approach of ancient medicine system, for example Ayurveda medicine, does not have enough scientific understanding of the ingredients that are used in Ayurvedic medicine. In order to extract more value, a scientific evaluation could increase its appeal to a wider audience.
Whilst anti-ageing products have a strong appeal to an older population, younger consumers are more attracted to products that can preserve their youthfulness. This is likely to be a growing trend in the future. The concept of anti-ageing should, therefore, include youth preservation as part of its objective.
How do you foresee the intervention of science and technology in anti-aeging in the coming years?
Looking for the sources of ageing and identifying the cause of aging is vital. Intervening at an earlier point of aging will lead to a better outcome. More research and understanding of the overall expression of the genes, alongside identifying and targeting gene expression patterns, specific genes which influence aspects of ageing, is required.
Denne historien er fra BioSpectrum Asia August 2022-utgaven av BioSpectrum Asia.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA BioSpectrum Asia
BioSpectrum Asia
How FemTech Spurt in APAC is Redefining Healthcare
Despite representing half the global population, women's health has historically received only a fraction of healthcare innovation and investment.
4 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
China's Colossal Ageing Population and Low Birth Rate Challenge
China's recent policy initiatives pertaining to long-term care insurance, maternity insurance expansion, and primary healthcare reform reflect a coordinated attempt to address deep structural demographic challenges—most notably 'rapid population ageing' and declining birth rates.
2 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
"We need to prioritise research as several common AYA cancers are significantly under-studied in Asian populations"
At the SingHealth Presidents' Scientific and Partners in Social-care (SPSOC) Conference, Assistant Professor Eileen Poon, Senior Consultant in Medical Oncology at the National Cancer Centre Singapore (NCCS) delivered an enlightening presentation.
7 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
Shimadzu Scientific Instruments opens laboratory in San Francisco Bay Area
Shimadzu Scientific Instruments (SSI) has opened its new research and development (R&D) facility in South San Francisco, California, US.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
NTU and NHG Health partner to advance healthcare education in Singapore
NHG Health's inaugural E3 (Educate, Elevate, Evolve) conference, held recently, was marked by a new partnership with Nanyang Technological University (NTU) Singapore, signalling a significant step in advancing healthcare education through interdisciplinary collaboration.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
"Building a lean team with deep operational expertise increases likelihood of success in rare disease drug development"
More than 300 million people worldwide are impacted by over 10,000 rare diseases, i.e. more than cancer and AIDS combined.
5 mins
BioSpectrum Asia May 2026
BioSpectrum Asia
Qiagen expands into bloodstream infection syndromic testing with new rapid QIAstat-Dx panel
Qiagen N.V. has announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
Royalty Pharma on-boards Kenneth Sun as Senior Vice President and Head of Asia
US-based Royalty Pharma ple has announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
Waters launches omniDAWN Multi-Angle Light Scattering (MALS) Photometer
US-based Waters Corporation has announced the launch of the Waters omniDAWN Multi-Angle Light Scattering (MALS) Photometer, part of the Wyatt Technology Portfolio.
1 min
BioSpectrum Asia May 2026
BioSpectrum Asia
South Korea's Cell and Gene Therapy Surge
South Korea's cell and gene therapy (CGT) landscape is highly dynamic, as observed from regulatory approvals, clinical development, and manufacturing activity.
5 mins
BioSpectrum Asia May 2026
Translate
Change font size
